Status:
RECRUITING
Gross Examinations Versus Frozen Section for Assessment of Surgical Margins in Oral Cancers
Lead Sponsor:
Dr.Pankaj Chaturvedi
Conditions:
Oral Cavity Cancer
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Surgical margin is a significant prognostic factor in oral cavity squamous cell carcinoma (OCSCC)\[1,2,3\]. Intra-operative frozen section (FS) has been routinely used by the surgeons to achieve adequ...
Eligibility Criteria
Inclusion
- Biopsy proven treatment naïve cases of OCSCC who are planned for curative surgery with en-bloc removal of the tumor with adequate margin
- In detail assessment of the primary tumor is possible pre-operatively
- Written informed consent
- Age more than 18 years
Exclusion
- Multifocal disease
- Clinically evident field cancerization
- Previous treatment for oral cavity cancer - Surgery /chemo or radiotherapy -
Key Trial Info
Start Date :
November 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2028
Estimated Enrollment :
1206 Patients enrolled
Trial Details
Trial ID
NCT04809324
Start Date
November 15 2021
End Date
June 1 2028
Last Update
April 11 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Tata Memorial Hospital
Mumbai, Maharashtra, India, 400012
2
ACTREC,Advanced Centre for Treatment, Research and Education in Cancer
Navi Mumbai, Raigad, India, -410210
3
Mahamana Pandit Madan Mohan Malaviya Cancer Centre
Varanasi, Uttar Pradesh, India, 221005